↓ Skip to main content

IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer

Overview of attention for article published in Frontiers in oncology, July 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
134 Dimensions

Readers on

mendeley
233 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer
Published in
Frontiers in oncology, July 2017
DOI 10.3389/fonc.2017.00140
Pubmed ID
Authors

Elzbieta Kania, Gemma Roest, Tim Vervliet, Jan B. Parys, Geert Bultynck

Abstract

Calcium ions (Ca(2+)) play a complex role in orchestrating diverse cellular processes, including cell death and survival. To trigger signaling cascades, intracellular Ca(2+) is shuffled between the cytoplasm and the major Ca(2+) stores, the endoplasmic reticulum (ER), the mitochondria, and the lysosomes. A key role in the control of Ca(2+) signals is attributed to the inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs), the main Ca(2+)-release channels in the ER. IP3Rs can transfer Ca(2+) to the mitochondria, thereby not only stimulating core metabolic pathways but also increasing apoptosis sensitivity and inhibiting basal autophagy. On the other hand, IP3-induced Ca(2+) release enhances autophagy flux by providing cytosolic Ca(2+) required to execute autophagy upon various cellular stresses, including nutrient starvation, chemical mechanistic target of rapamycin inhibition, or drug treatment. Similarly, IP3Rs are able to amplify Ca(2+) signals from the lysosomes and, therefore, impact autophagic flux in response to lysosomal channels activation. Furthermore, indirect modulation of Ca(2+) release through IP3Rs may also be achieved by controlling the sarco/endoplasmic reticulum Ca(2+) ATPases Ca(2+) pumps of the ER. Considering the complex role of autophagy in cancer development and progression as well as in response to anticancer therapies, it becomes clear that it is important to fully understand the role of the IP3R and its cellular context in this disease. In cancer cells addicted to ER-mitochondrial Ca(2+) fueling, IP3R inhibition leads to cancer cell death via mechanisms involving enhanced autophagy or mitotic catastrophe. Moreover, IP3Rs are the targets of several oncogenes and tumor suppressors and the functional loss of these genes, as occurring in many cancer types, can result in modified Ca(2+) transport to the mitochondria and in modulation of the level of autophagic flux. Similarly, IP3R-mediated upregulation of autophagy can protect some cancer cells against natural killer cells-induced killing. The involvement of IP3Rs in the regulation of both autophagy and apoptosis, therefore, directly impact cancer cell biology and contribute to the molecular basis of tumor pathology.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 233 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 233 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 54 23%
Student > Bachelor 34 15%
Student > Master 23 10%
Researcher 19 8%
Student > Doctoral Student 10 4%
Other 29 12%
Unknown 64 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 77 33%
Agricultural and Biological Sciences 21 9%
Neuroscience 12 5%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Medicine and Dentistry 9 4%
Other 32 14%
Unknown 70 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2017.
All research outputs
#15,523,434
of 25,382,440 outputs
Outputs from Frontiers in oncology
#4,858
of 22,428 outputs
Outputs of similar age
#176,279
of 325,782 outputs
Outputs of similar age from Frontiers in oncology
#34
of 79 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,428 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,782 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.